VLA viralytics limited
Add to My Watchlist 0.00% ! $1.75

I'm pretty sure that it would not be in Merck's best interest to...

  1. DavieJones
    255 Posts.
    lightbulb Created with Sketch. 35
    clock Created with Sketch.
    06/01/17
    13:45
    Post #: 21722930

    I'm pretty sure that it would not be in Merck's best interest to present anything from the STORM/KEYNOTE trial. Why give a leg-up to potential bidders / competitors ? Merck will be keen to keep all of the results hushed up until they are prepared to licence/partner/acquire the technology if the trial is successful.

    .
    VLA Price at posting: $1.21 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS MTM Successful Uplisting Commences Trading on OTCQX Market in US
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming
right-arrow Created with Sketch.
NEWS Paris Gold Project Drilling Underway Testing High-Grade Zones
right-arrow Created with Sketch.
NEWS More Outstanding Gallium Assay Results for Nimy at Block 3
right-arrow Created with Sketch.
NEWS R&D Tax Refund of $5.8M Received by Imugene to Support Clinical Development
right-arrow Created with Sketch.
NEWS Austral Resources to Acquire Rocklands to Transform North-West Queensland Copper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.